BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23580936)

  • 1. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system.
    Shirsand S; Para M; Nagendrakumar D; Kanani K; Keerthy D
    Int J Pharm Investig; 2012 Oct; 2(4):201-7. PubMed ID: 23580936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of niosomal gel of fusidic acid: in-vitro and ex-vivo approaches.
    Waqas MK; Sadia H; Khan MI; Omer MO; Siddique MI; Qamar S; Zaman M; Butt MH; Mustafa MW; Rasool N
    Des Monomers Polym; 2022; 25(1):165-174. PubMed ID: 35711622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
    Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
    Rane BR; Chavan PY; Kate NS; Jain AS
    Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation.
    Shilakari Asthana G; Asthana A; Singh D; Sharma PK
    J Drug Deliv; 2016; 2016():9324567. PubMed ID: 27478643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonionic surfactant-based vesicular system for transdermal drug delivery.
    Ghanbarzadeh S; Khorrami A; Arami S
    Drug Deliv; 2015 Dec; 22(8):1071-1077. PubMed ID: 24400680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
    Jain N; Verma A; Jain N
    Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin.
    Shilakari Asthana G; Sharma PK; Asthana A
    Scientifica (Cairo); 2016; 2016():6492953. PubMed ID: 27293976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation optimization,
    Aldawsari MF; Khafagy ES; Moglad EH; Selim Abu Lila A
    Saudi Pharm J; 2023 Sep; 31(9):101734. PubMed ID: 37649675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serratiopeptidase Niosomal Gel with Potential in Topical Delivery.
    Shinde UA; Kanojiya SS
    J Pharm (Cairo); 2014; 2014():382959. PubMed ID: 26556195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
    Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery.
    Teaima MH; El Mohamady AM; El-Nabarawi MA; Mohamed AI
    Drug Dev Ind Pharm; 2020 May; 46(5):751-761. PubMed ID: 32250181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-by-Design-Assisted Optimization of Carvacrol Oil-Loaded Niosomal Gel for Anti-Inflammatory Efficacy by Topical Route.
    Ghazwani M; Hani U; Alam A; Alqarni MH
    Gels; 2023 May; 9(5):. PubMed ID: 37232993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes.
    Taymouri S; Varshosaz J
    Adv Biomed Res; 2016; 5():48. PubMed ID: 27110545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery.
    Akhtar N; Arkvanshi S; Bhattacharya SS; Verma A; Pathak K
    J Liposome Res; 2015 Sep; 25(3):191-201. PubMed ID: 25357198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.